SDG3 Newsletter: Access for All

This Springer Nature SDG 3 Newsletter focuses on the importance of equity in healthcare and academic publishing to ensure progress towards Sustainable Development Goal 3, good health and wellbeing for all. Explore research Q&As, blogs highlighting books, articles, open collections, and more!
SDG3 Newsletter: Access for All
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

This SDG 3 Newsletter relates mainly to SDG target 3.8 

In the blogs, find answers to the 5 quiz questions dotted throughout the newsletter. Comment the answers below to be named as a top scorer in the October newsletter! 📢

Use these links to navigate to a section:

In other news…

Access denied: the impact of censorship on SDG 3🚫

Keep up-to-date with this blog that explores how recent restrictions on language in US academic publications that limit the use of terms including ‘breastfeed’, ‘climate’, ‘Black’, ‘female’, and ‘sex’ could undermine research integrity and stall progress toward the SDG 3 targets.

🔐Currently, how many words have the US Federal Agencies restricted: 100+, 350+, or 1,000?

Book Q&A: Anaesthesia in Remote Hospitals with Dr Daniela Kietzmann📗

Read this blog where Dr Kietzmann highlights the global lack of access to safe anaesthesia, sharing her experiences in remote hospitals and advocating for essential improvements to protect patients undergoing surgery worldwide.

🔐Within a 500km radius in Tanzania's Southern Zone, what is the typical maximum number of anaesthesiologists: 3, 5, or 10?

Book spotlight: Climate change and Mental Health Equity📖

Don't miss this blog discussing Rhonda J. Moore’s book, Climate Change and Mental Health Equity. It explores how environmental stress intensifies mental health struggles in marginalised communities, calling for culturally sensitive care and urgent policy reform.

Genomics England Health Summit 2025: DEI in genomic medicine🧬

Learn about the Genomics England Health Summit 2025 which showcased efforts to enhance genomic testing and diagnostic accuracy for underrepresented groups, with research aimed at improving outcomes for patients from LMICs and ethnic minority backgrounds.

🔐According to Professor Catherine Williamson’s presentation, are Black women twice as likely, 3 times as likely, or 5 times as likely to die from pregnancy-related complications?

From discovery to real-world applications: a Q&A with Dr Florence Bietrix🧪

Read this Q&A where Dr Florence Bietrix, Section Editor at Journal of Translational Medicine, emphasises turning biomedical discoveries into practical, inclusive healthcare solutions.

World Population Day: the importance of social connection for population health🫂

Don't miss this blog for World Population Day, where the Editors-in-Chief of Population Health Metrics highlight the vital role of social connection in population health research and policy. Look out for a forthcoming journal collection on the topic!

Meeting people where they are: harm reduction and access to healthcare🗣️

Read this blog to learn why harm reduction community programmes and policy reforms are critical to meeting the SDG 3 targets. Harm reduction expands access to healthcare by reducing stigma, building trust and addressing inequality.

Open collection: ‘Migration and its Effects on Maternal and Child Health and Nutrition’🤱

Check out this blog about a collection open in Journal of Health, Population and Nutrition and International Journal for Equity in Health. The blog explores how migration affects maternal and child health and nutrition, emphasising the need for equitable access to healthcare and policy solutions that support vulnerable migrant populations. Submit to the collection here!

🔐Which SDG 3 target does this collection relate to? 3.1, 3.5 or 3.8?

Addressing gender gaps in clinical trials 🔬

Women remain underrepresented in clinical trials. Learn why in this blog. 

The state of bias in scientific publishing🔍

Read about a recent analysis of gender representation throughout the publishing process at Nature Portfolio, and what is being done to address gender disparities.

🔐How many corresponding authors were included in the analysis? 10,000, 100,000 or 215,000?

In other news...

Increased risk of infectious diseases in a time of war and conflict🦠

In this BugBitten blog, Professor Krisztian Magori offers his insights into the impact of war and recent conflicts on infectious diseases and the level of compliance to international humanitarian protection laws. 

Interview with Rohit P. Shenoi, winner of the Jess Kraus Award in Injury Epidemiology🏆

See this Q&A where the Editor-in-Chief of Injury Epidemiology, Professor Guohua Li, chats with this year’s recipient of the Jess Kraus Award, Dr Shenoi, about his award-winning article on drowning. There will be an award ceremony and a seminar presentation by Dr Shenoi at Columbia University this autumn/fall.

Upcoming webinar: Gender identity in Indigenous communities

Sign up here!

Get involved! 

Thank you to everyone who contributed to this newsletter.* If you would like to be involved with our SDG 3 initiatives, contact me. Follow me, Alice Coe, on Research Communities to be notified of future SDG 3 newsletters.

*With special thanks to: Yasmin Wilczur, Dr Daniela Kietzmann, Liz Chamberlain, Sophie Gray, Abiola Lawal, India Sapsed-Foster, Dr Florence Bietrix, Suzuki Limbu, Prof Shereen Hussein, Prof Jonathan Samet, Virginia Mercer, Louis Gautier, Prof Guohua Li, Dr Rohit P. Shenoi, and the BugBitten blog channel

Comment your quiz answers to be featured in the October newsletter! The next newsletter will focus on women's health.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Public Health
Life Sciences > Health Sciences > Public Health
Biochemistry
Life Sciences > Biological Sciences > Chemical Biology > Biochemistry
SDG 3: Good Health & Wellbeing
Research Communities > Community > Sustainability > UN Sustainable Development Goals (SDG) > SDG 3: Good Health & Wellbeing

Related Collections

With Collections, you can get published faster and increase your visibility.

Measuring Population Health in the Era of Climate Change

Measuring Population Health in the Era of Climate Change

Climate change is increasingly recognized as a major challenge for population health worldwide. Rising global temperatures, more frequent and severe extreme weather events, and changing seasonal patterns affect mortality, morbidity, and broader population health dynamics across countries and regions. These impacts are not distributed equally across populations, with older adults, socioeconomically disadvantaged populations, people from culturally and linguistically diverse backgrounds, Indigenous populations, and other vulnerable groups often facing disproportionate risks.

A growing body of research has documented the adverse health impacts of climate-related exposures, including heat and cold, floods, droughts, and wildfires. Over recent decades, substantial progress has been made in improving methodologies for assessing climate-health associations, increasing the availability and granularity of environmental, geospatial, and health data, and developing cross-national initiatives aimed at strengthening the evidence base. Nevertheless, important challenges remain in measuring and comparing climate-related health impacts across population subgroups, geographical contexts, and time periods.

This Special Collection seeks contributions that advance the measurement and understanding of climate-related impacts on population health. We welcome ecological and population-level studies, methodological innovations in estimating the burden associated with non-optimal temperatures and extreme weather events, and improved approaches for measuring excess mortality and mortality displacement. We also encourage contributions examining seasonality and temporal dynamics in population health, climate-related impacts on non-communicable diseases and mental health conditions, and the interplay between climatic, behavioural, and socioeconomic determinants of health outcomes. Contributions focusing on low- and middle-income countries are particularly welcomed.

Relevant contributions include, but are not limited to:

  • Methodological innovations in measuring and modelling climate-related impacts on non-communicable, mental, and infectious diseases
  • Advances in measuring excess mortality and short-term mortality displacement (harvesting) associated with extreme weather events
  • Determinants of seasonal variation in mortality and morbidity across climatic zones and population groups
  • Small-area estimation and spatial modelling of local climate impacts on population health
  • Measuring climate-related health outcomes in data-constrained settings
  • Comparative and cross-national studies of the socioeconomic, behavioural, and demographic determinants of climate-related health outcomes
  • Population vulnerability, adaptation, and resilience to climate-related health risks
  • Healthy ageing in a changing climate
  • Forecasting and scenario-based approaches to climate-related population health burdens

This Collection welcomes original research articles, methodological contributions, interdisciplinary studies, comparative analyses, and systematic reviews that align with the scope of Population Health Metrics.

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Feb 26, 2027

Computational Modelling and Network Medicine in Drug Toxicology and Clinical Pharmacovigilance

Computational approaches are becoming indispensable in the field of translational pharmacology and systems medicine. In particular, the integration of computational modelling and network medicine is reshaping our understanding of drug toxicity, safety profiling, and clinical pharmacovigilance. With the rapid accumulation of multi-omics, electronic health records, and real-world pharmacovigilance data, there is an urgent need for advanced computational frameworks to identify hidden drug–target–phenotype associations and elucidate mechanisms underlying adverse drug reactions (ADRs) and toxicities. Drug toxicology and pharmacovigilance are key components of translational medicine, bridging molecular mechanisms with patient outcomes. However, predicting and preventing drug-induced toxicities remain challenging due to the complexity of biological systems and individual heterogeneity. Network-based and machine learning methods, such as graph neural networks, causal inference, and mechanistic modelling, are providing new opportunities to reveal system-level toxicity pathways, optimize drug safety assessment, and enhance early signal detection in clinical practice.

This collection aims to gather latest research and comprehensive reviews that explore computational, network-based, and AI-driven strategies in drug toxicology and pharmacovigilance. We seek contributions that demonstrate how integrative modelling, network pharmacology, and multi-scale data analysis can advance the prediction, understanding, and management of drug-related adverse effects, ultimately contributing to safer and more effective therapeutics.

Potential topics include, but are not limited to:

- Computational modelling for drug toxicity prediction

- Network medicine approaches to drug safety and toxicity mechanisms

-Machine learning and AI in pharmacovigilance signal detection

-Integrative modelling of drug–target–pathway interactions

-Systems pharmacology and multi-omics network analysis in toxicology

-Network-based biomarker discovery for adverse drug reactions

-Data-driven prediction of idiosyncratic and immune-related toxicities

-Translational applications of network and computational models in clinical drug safety assessment

All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Sep 07, 2026